DexCom, Inc. vs. Abbott Diabetes Care Inc.
Explore the PTAB proceeding IPR2023-01252 filed by DexCom, Inc. on 2023-08-01. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2023-01252
Filing Date
2023-08-01
Accorded Filing Date
2023-08-01
Institution Decision Date
2024-02-05
Last Modified Date
2024-08-19
Proceeding Type
IPR
Termination Date
2024-02-05
Trial Status
Institution Denied
Parties & Counsel
Petitioner
DexCom, Inc.
Represented By
Vandenberg, Johnet alPatent Owner / Respondent
Abbott Diabetes Care Inc.
Represented By
McAndrews, Peteret alTribunal & Venue
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Patent Information
Respondent Application Number
17411154
Respondent Patent Number
11298056
External Links
Respondent Inventor
Wesley Scott Harper
Respondent Tech Center
TC 1600 - Biotechnology & Organic Chemistry
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Firm
/ Entity Name
One LLP - ADC - Alana Fredericks
Customer
Number
183890
Address
23 Corporate Plaza, Suite 150, Newport Beach, CA, 92660, UNITED STATES
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 33349 | Thomas Rendos | 651-756-6480 |
| 39046 | Mimi Goller | 847-935-7550 |
| 40499 | Audrey Bartnicki | 847-938-3440 |
| 41091 | Jonathan Jaech | 949-444-5941 |
| 45455 | Jon Trachtenberg | 978-577-3417 |
| 47004 | Rachel Polster | 847-937-0107 |
| 47822 | Peter Nichols | 818-493-2323 |
| 48056 | Chien Yuan | 914-524-2094 |
Proceeding Documents
31
12
Petitioners Request For Refund Of The Post-Institution Fee OTHER
2024-08-19
FILING PARTY: PETITIONER
11
Notice: refund approved NOTICE
2024-02-23
FILING PARTY: BOARD
10
Petitioners Request For Refund Of The Post-Institution Fee OTHER
2024-02-21
FILING PARTY: PETITIONER
9
Institution Decision: Deny DECISION
2024-02-05
FILING PARTY: BOARD
7
Patent Owner's Preliminary Response POPR
2023-11-10
FILING PARTY: PATENT OWN